Decentralized Clinical Trials

In October 2019, ACRO established the Decentralized Clinical Trials Working Party to examine the barriers to adoption of DCTs and create quality-based principles and tools to facilitate implementation of decentralized clinical trials.

Thought Leadership on DCTs

In September 2020, ACRO released a White Paper to provide an overview of key issues in the decentralization of clinical trials and to introduce two DCT tools: a Quality-by-Design Manual and a Template for DCT Risk Assessment Considerations.

Advancing DCTs

ACRO members are dedicated to helping bring quality-based principles, risk-assessment tools, and patient-centricity to the decentralized trials process.

Explore some of ACRO’s additional DCT resources: